GlaxoSmithKline PLC (GSK)
41.33
+0.08 +0.19%
NYSE
Aug 20, 20:00
Delayed 2m
USD
View All Key Stats
GSK Key Stats
| Income Statement | |
| Revenue (TTM) | 40.41B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.9005 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 2.226B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.40% |
| Profit Margin (Quarterly) | 6.03% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 102.50B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.533 |
| PE Ratio (TTM) | 45.90 |
| Price to Book Value | 21.31 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.331B |
| Return on Equity (TTM) | Upgrade |
View All GSK News
GSK News
-
WireHeadlineTime (ET)
-
MT Newswires08/21 05:59
-
SA Breaking News08/20 11:08
-
Yahoo08/20 10:29
-
MT Newswires08/20 07:27
-
SA Breaking News08/17 18:15
-
Yahoo08/17 16:40
-
Yahoo08/17 09:34
-
Yahoo08/17 09:01
-
Yahoo08/17 04:24
-
MT Newswires08/16 15:28
View All Events
GSK Events
| Date | Type | Description |
|---|---|---|
| 02/07/2019 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2018 |
| 10/31/2018 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2018 |
| 08/09/2018 | Dividends | Amount: 0.5011, Declared Date: Jul 25 2018, Pay Date: Oct 11 2018 |
| 07/25/2018 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2018 |
| 05/10/2018 | Dividends | Amount: 0.5298, Declared Date: Apr 27 2018, Pay Date: Jul 12 2018 |
| 05/03/2018 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2017 |
| 04/25/2018 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2018 |
| 03/13/2018 | Misc | GlaxoSmithKline PLC Annual Report in 2017 |
| 02/22/2018 | Dividends | Amount: 0.6385, Declared Date: Feb 07 2018, Pay Date: Apr 12 2018 |
| 02/07/2018 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2017 |
GSK Fundamentals
Income Statement View Statement
GSK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GSK One Page Reports
- One Page Report Download
GSK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 41.33 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Oct. 31, 2018
- Last Earnings Release: Jul. 25, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 09, 2018
- Description: GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
GSK Excel Add-In Codes
- Name: =YCI("GSK","name")
- Description: =YCI("GSK","description")
- Sector: =YCI("GSK","sector")
- Industry: =YCI("GSK","industry")
- Est. Current Fiscal Year End: =YCI("GSK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GSK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
